View in EDS HTML Full Text PDF Full Text

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Saved in:
Bibliographic Details
Title: Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
Authors: Ci, Xinpei1 (AUTHOR), Chen, Sujun1,2 (AUTHOR), Zhu, Rui1 (AUTHOR), Zarif, Mojgan1 (AUTHOR), Jain, Rahi1 (AUTHOR), Guo, Wangyuan1 (AUTHOR), Ramotar, Matthew1 (AUTHOR), Gong, Linsey1,3 (AUTHOR), Xu, Wenjie4 (AUTHOR), Singh, Olivia1 (AUTHOR), Mansouri, Sheila1 (AUTHOR), Zadeh, Gelareh1,5 (AUTHOR), Wei, Gong-Hong4 (AUTHOR), Xu, Wei1 (AUTHOR), Bristow, Robert6,7 (AUTHOR), Berlin, Alejandro1 (AUTHOR) alejandro.berlin@rmp.uhn.ca, Koritzinsky, Marianne1,3,8,9 (AUTHOR) marianne.koritzinsky@uhnresearch.ca, van der Kwast, Theodorus1,10 (AUTHOR) theodorus.vanderkwast@uhn.ca, He, Housheng Hansen1,3 (AUTHOR) hansenhe@uhnresearch.ca
Source: BMC Cancer. 6/18/2024, Vol. 24 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-024-12505-1